Quality Assurance & Control Resource Center
Oral solid dose manufacturers may not be reinventing the wheel – but they are fine-tuning it
If not handled properly, remediation efforts can become sizable and expensive; fortunately, companies can draw on the structured remediation experiences of other companies who have emerged from crisis
How Catalent’s approach to containment mitigates cross-contamination risk and regulatory issues, ultimately safeguarding patients
Many pharma companies today continue to work on resolving issues and process deviations rather than emphasizing what it takes to build products and processes that are robust
White Papers: In Depth Research
Posted: Oct 02, 2014
To properly and accurately calibrate and adjust relative humidity instruments is no simple task.
Solutions Update: Quality, Compliance, Regulatory and Risk Management Solutions for the Increasingly Complex Pharmaceutical Industry
Posted: Sep 02, 2014
While market globalization has opened opportunities for pharmaceutical manufacturers, it has also intensified competition and the pressure to produce faster and at a lower cost.
Posted: Aug 25, 2014
Posted: Jul 30, 2014